시장보고서

상품코드

1863959

펩타이드 치료제 시장 : 제품 종류별, 용도별, 투여 경로별, 지역별

Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region

발행일: 2025년 10월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

펩타이드 치료제 시장은 2025년에 504억 3,940만 달러로 추정되며, 2032년까지 788억 9,880만 달러에 달할 것으로 예측됩니다. 2025년부터 2032년까지 CAGR 6.6%로 성장할 것으로 전망됩니다.

보고서 내용		보고서 상세
기준 연도	2024년	시장 규모(2025년)	504억 3,940만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 CAGR(2025-2032년)	6.60%	예측 금액(2032년)	788억 9,880만 달러

펩타이드 의약품 개발은 새로운 제조기술, 변형기술, 분석기술의 발전으로 괄목할만한 성장을 거듭하고 있습니다. 화학적 및 생물학적 방법을 이용한 펩타이드의 생성 및 변형과 더불어 펩타이드 고유의 문제를 극복하는 새로운 설계 및 전달 전략이 확립되어 이 분야의 지속적인 발전이 가능해졌습니다. 심장대사질환, 면역학, 피부과학, 종양학 등 다양한 치료 영역을 커버하는 수많은 천연 펩타이드 및 변형 펩타이드가 도출되어 연구가 진행되고 있습니다. 펩타이드 의약품 개발은 21세기에 접어들면서 새로운 시대를 맞이하였고, 구조 생물학, 재조합 생물학적 제제, 새로운 합성 및 분석 기술의 발전으로 인해 그 과정이 눈에 띄게 가속화되었습니다. 펩타이드 신약개발, 약물 설계, 펩타이드 합성, 구조 변형, 활성 평가를 포함한 정교한 펩타이드 의약품 개발 시스템이 구축되어 있습니다.

치료용 펩타이드는 일반적으로 분자량 500-5000달톤(Da) 범위의 규칙적인 아미노산 서열로 구성된 독특한 의약품 클래스입니다.

시장 역학

시장 기업들은 생체적합성과 강력한 치료 효과를 높여 대상 환자에게 맞춤형 솔루션을 제공하는 혁신적이고 새로운 펩타이드 치료제를 개발하고 있습니다. 암, 심혈관질환, 당뇨병의 유병률 증가는 예측 기간 동안 펩타이드 치료제 시장의 성장을 견인할 것으로 예상됩니다.

시장의 주요 업체들이 제품 포트폴리오를 확장하기 위해 제휴와 같은 유기적 성장 전략을 채택하는 움직임이 증가하고 있으며, 이는 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2023년 1월에는 세계 최대 제약사 릴리와 세계 헬스케어 기업 머크가 펩타이드 표적 약물전달 기술 관련 제휴를 발표하며 바이오 제약사 펩티드라임 인수를 위해 협력할 것을 밝혔습니다.

본 보고서의 주요 특징

세계의 펩타이드 치료제 시장을 상세히 분석하고, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 CAGR을 조사하여 전해드립니다.
또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
세계 펩타이드 치료제 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 정리하여 수록하고 있습니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
"세계 펩타이드 치료제 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 펩타이드 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 50,439.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.60%	2032 Value Projection:	USD 78,898.8 Mn

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study

This report provides in-depth analysis of the global peptide therapeutics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Peptide Therapeutics Market Segmentation

Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Branded Peptide
- Generic Peptide
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Cancer
- Cardiovascular diseases
- Metabolic diseases
- Respiratory diseases
- Infectious diseases
- Others
Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral Administration
- Parenteral Administration
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Teva Pharmaceutical Industries Ltd
- Novo Nordisk A/S
- OPKO Health Inc.
- Lilly
- Hanmi Pharm.Co.
- Sanofi
- Circle Pharma
- Pfizer Inc.
- Novartis AG
- PeptiDream Inc.
- Amgen Inc.
- AstraZeneca
- Bachem Holding AG
- CordenPharma International
- Ipsen Pharma
- Merck KGaA
- PolyPeptide Group
- Bayer AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Global Peptide Therapeutics Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Peptide Therapeutics Market, By Product Type, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Branded Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Generic Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Peptide Therapeutics Market, By Application, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Metabolic Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Peptide Therapeutics Market, By Route of Administration, 2020-2032, (US$ Million)

Oral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Parenteral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Global Peptide Therapeutics Market, By Region, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hanmi Pharm.Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Circle Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PeptiDream Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bachem Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CordenPharma International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

펩타이드 치료제 시장 : 제품 종류별, 용도별, 투여 경로별, 지역별

Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region

시장 역학

목차

제1장 분석 목적과 가정

제2장 시장 전망

제3장 시장 역학·규제·동향 분석

제4장 세계의 펩타이드 치료제 시장 : 신종 코로나바이러스 감염증(COVID-19) 팬데믹의 영향

제5장 세계의 펩타이드 치료제 시장 : 제품 종류별(2020-2032년)

제6장 세계의 펩타이드 치료제 시장 : 용도별(2020-2032년)

제7장 세계의 펩타이드 치료제 시장 : 투여 경로별(2020-2032년)

제8장 세계의 펩타이드 치료제 시장 : 지역별(2020-2032년)

제9장 경쟁 구도

제10장 섹션